Navigation Links
Concentric Medical Closes on $15 Million Financing
Date:1/8/2009

MOUNTAIN VIEW, Calif., Jan. 8 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that it has completed a $15 million round of financing. The round was led by leading venture capital firm New Enterprise Associates, Inc. (NEA) and includes other existing investors and new investors.

"The positive developments at Concentric over the last several months made the opportunity to participate in this round of financing very attractive to investors," said Robert Thomas, Chairman of Concentric's Board of Directors. "Concentric ended 2008 very successfully, launching multiple new products and expanding its distribution footprint both in the United States and in Europe. Concentric plans to accelerate market development through diversified technology and additional clinical trials, positioning the company well for 2009 and beyond."

Commenting on this announcement, Maria Sainz, President and Chief Executive Officer of Concentric said, "This show of support, particularly in the current financial environment, is very gratifying and represents a strong vote of confidence for the company's strategic plans going forward."

Business Developments

Significant activities during recent months include:

In July 2008, Concentric launched its third generation of Merci Retrievers(R), the V-Series, which incorporates elements of the Merci(R) X6 Retriever and the Merci(R) L-Series Retrievers into an innovative variable pitch design. The V-Series is available in multiple configurations and sizes to match patient anatomy, and further extends the company's lead in the acute ischemic stroke market.

In September 2008, Concentric expanded its global distribution network by opening Concentric Medical SPRL, a Belgian subsidiary dedicated to providing sales and marketing support to Concentric Medical, Inc.'s European sales force. During the second half of 2008 Concentric doubled the size of its European sales team.

In October 2008, Concentric launched the Outreach(TM) Distal Access Catheter, a highly deliverable, small diameter catheter designed to provide distal access and support in tortuous anatomy. The Outreach Distal Access Catheter provides neurointerventionalists easier distal access and enhanced support during minimally invasive procedures in the brain, and will serve as the platform for a wide array of products Concentric plans to release during 2009.

About Concentric Medical

Concentric Medical is located in Mountain View, California, and was founded in August 1999. The company manufactures and markets the Merci Retrieval System(TM), which is a minimally invasive device that is delivered by a neurointerventionalist into the brain to restore blood flow by removing blood clots that cause ischemic stroke. The Merci Retrieval System is available in over 250 leading stroke centers around the world, and has been the subject of two successful clinical trials, MERCI and Multi MERCI. Concentric Medical estimates that over 9,800 patients have been treated with its devices. For more information about Concentric Medical, please visit www.concentric-medical.com.

    Media Contact: Andrew Chmyz
    1 650-810-1702
    achmyz@concentric-medical.com


'/>"/>
SOURCE Concentric Medical
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
2. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
3. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
4. China Sky One Medical, Inc. Qualifies for Preferential Income Tax Rate
5. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
6. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
7. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
8. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
9. China Sky One Medical, Inc. Receives Scientific Achievement Award
10. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
11. ICU Medical Inc. and Health Robotics Announce Compatibility of CytoCare(TM) Robot and CLAVE(R) Needle-Free Connector to Enable Safer Hazardous Drug Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Aethlon Medical, Inc. (Nasdaq: AEMD ... validated the ability of the Aethlon Hemopurifier® to capture ... in immune-suppressed sepsis patients and also contribute to organ ... of the study was to validate the in ... and Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. ...
(Date:2/22/2017)... Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 ... ) today announced its financial results for the ... "Our annual 2016 financial results reflect continued ... earnings exceeded $700 million," said Martine Rothblatt, Ph.D., ... financial results strengthen our ability to develop and ...
(Date:2/21/2017)... MENLO PARK, CA (PRWEB) , ... February 21, ... ... launch of the VTX-1 Liquid Biopsy System , a fully automated benchtop ... using microfluidic technology. The VTX-1 is being launched at the Molecular Medicine Tri ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... division, Treximo will pair its $200M operational capacity with its strategic internal ... management in areas affecting quality and operational management. With office locations ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
Breaking Biology News(10 mins):